NEOADJUVANT CHEMOTHERAPY IN HEAD AND NECK CANCER: RESULTS OF A GSTTC PHASE III TRIAL WITH A 10 YEAR MINIMUM FOLLOW UP


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles